肝细胞癌的分子和免疫景观,以指导治疗决策
Renumathy Dhanasekaran1, Hiroyuki Suzuki2, Lea Lemaitre1
1Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University, Stanford, California, USA.
Hepatology (Baltimore, Md.)
|June 10, 2023
概括
了解肝癌 (HCC) 的异质性是开发有效生物标志物的关键. 综合性分析有助于个性化治疗,并改善患者对这种致命疾病的治疗结果.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 免疫学 免疫学 免疫学
背景情况:
- 肝细胞癌 (HCC) 显示出显著的瘤间和瘤内异质性.
- 这种异质性会影响疾病进展,临床结果和治疗反应.
研究的目的:
- 审查了解HCC异质性的近期进展.
- 探索分子和免疫生物标志物的潜力,以实现个性化的HCC治疗.
- 讨论生物标志物指导临床试验中的挑战和新策略.
主要方法:
- 综述多模式,单细胞和空间空间信息分析技术.
- 对HCC中分子和免疫景观发现的分析.
- 检查生物标志物评估框架和临床试验设计.
主要成果:
- 先进的奥米克技术揭示了HCC细胞和瘤免疫微环境中的复杂异质性.
- 生物标志物对于个性化治疗决策和优化治疗疗效至关重要.
- 新的临床试验设计正在出现,以应对生物标志物的翻译挑战.
结论:
- 对HCC异质性的全面表征对于生物标志物发现至关重要.
- 由生物标志物指导的策略有望彻底改变HCC患者护理和降低死亡率.
- 个性化医疗方法对于有效的HCC管理至关重要.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.3K
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
01:27Cytotoxic T Cells-mediated Immune Response
999
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
999